Reneuron Share Discussion Threads

[bradders51] 19/11/2021 12:03

Just up a couple of pence as I type. We'll probably end up red today :-0
Funny old game ain't it ??

[martinfrench] 19/11/2021 11:09

its not technically an RNS (says non RNS) but who cares, the news is clearly out there, as long as it reaches the right channels.....?

maybe reasons not a full blown RNS, if not, mistake by RENE

just get this stuff bloody commercail, this company has huge potential but never sure what the commercial side (new hires etc) are exactly doing ???

[luffness] 19/11/2021 09:12

Reach not RNS

[philh75] 19/11/2021 09:02

It is an RNS

[bradders51] 19/11/2021 07:09

The news this morning about CTX-iPSC platform data seems absolutely brilliant. I don't quite understand why it's not an RNS.

[zho] 18/11/2021 09:13

"Another example is the Shanghai Key Laboratory of Stem Cell Therapy we established, the first of its kind led by a private enterprise. Focusing on regenerative medicine, the laboratory is now driving the development of two stem cell therapy products, one for stroke recovery, the other for treating pigmentary retinal degeneration, both of which are in high demand."

[dickbush] 16/11/2021 16:20

1,000 share sale included in the sale total as 100,000. See trade number 37.

[martinfrench] 16/11/2021 12:36

its unfortunately the same old problem with reneuron....

they are just simply not commercially focused, has always been their problem in my view

they just want us to fund projects and get stuff published if you ask me

[bradders51] 15/11/2021 20:20

PDT. Agreed. Not sure why the slide in the price after the exosomes results??
Seems a no-brainer to me. BWTFDIK
Hoping to just sneak in under £1 this week.

[pdt] 15/11/2021 16:17

Thanks for posting that video.

One of the slides shows results on Ovarian cancer cell lines and a mention that a scientific paper will be published soon. It will be interesting to see those results but they are clearly showing some anti-cancer effects.

There is an associated video showing that Rene is a 30% partner in that collaboration alongside IgInnovations (Abbott) and Swansea Uni.

Interesting times. I added to my holding since within the next six months I expect RP news and perhaps more Exosome news. Either of which could substantially rerate the share price from this level.

[rayrac] 10/11/2021 07:54

Yes very

This is the only UK share I hold now..everything else is Canadian markets.

[small crow] 09/11/2021 09:19

Nice find.

[pawelkordala] 09/11/2021 08:07

https://youtu.be/0FFOfTsCR7Q Looks like one of the secret exosomes collaborations is with Abbott and Reneuron is happy with the collaboration results so far...

[rayrac] 08/11/2021 10:04

Advfn not updating rene. Behind the times!

[small crow] 28/10/2021 12:40

Looks like a total of 600,000 bought yesterday, all marked as questions?

[small crow] 28/10/2021 12:36

Interesting moves at 12.35.

[dickbush] 28/10/2021 11:40

Alphapig, there are less than 57 million shares in issue. Mind you, by the time they get a valuable product into the market, you might be right.

I don't trash the management for the behaviour of the share price on a day to day or even year to year basis. Its share price performance long term-which is what I'm interested in- will be determined by its ability to translate research into a valuable, marketable product, and I've been in this long enough to remember when the company's lead product was going to alleviate the after effects of a stroke. So, I'm not starry-eyed.

I agree completely with a previous poster. This is either going to boom or go bust, with not much in between. Unfortunately, it has so far been a promises, promises experience as they hopped from one great hope to the next. Having said that, I've never seen Hellebo so excited as he was in his recent discussion of the company's work on exosomes. Also, the new Chief Scientific Officer looks like the real deal. So, aware that, once again, I may be being taken for a ride, my gambling money is on the table.

[small crow] 26/10/2021 11:51

Translated from the Italian??

[zho] 26/10/2021 11:31

Disappointed to see the misuse of 'alternate' in today's RNS. Might have to sell my shares ;-)

[rayrac] 26/10/2021 10:25

Btw, customers come only after successful trials! What the heck, or who, would you call a passenger?

[rayrac] 26/10/2021 09:46

Well, if they do have a sign of success with this in cancer, then you can bet AZN etc will take a strong interest in rene. AZN in particular, have a strong presence in cancer drugs.

[deutsch4] 26/10/2021 09:25

Jam tomorrow - its customers we want - not passengers.

[ayl30] 26/10/2021 07:30

From rns, glad you all understand this"ReNeuron will be providing UCL with iPSCs from its CTX immortalised neural progenitor cell line to be assessed for their ability to differentiate into functional T cells and natural killer ('NK') cells. If this first objective is met, the CTX-iPSC cell line will be further used to generate chimeric antigen receptors ('CAR') T cells and/or CAR-NK cells. CARs allow T and NK cells to target receptors present on the surface of cancer cells, allowing them to recognise and specifically kill tumour cells. Dr Roddie and her team have extensive expertise in generating CAR cells and both groups will work collaboratively to generate haematopoietic stem cells, lymphoid progenitors and cytotoxic T cells from the CTX-iPSCs."

[bradders51] 23/10/2021 07:04

With thanks to Balerno1 on the other thread.
This is a good read: Very positive on Rene.

Allenby assessing a fair value of 358p only based on hrpc. hxxp://www.allenbycapital.com/research/research-rene.html